Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a national registry unlock better care for kids with eosinophilic esophagitis?

NCT ID NCT07772388

Knowledge-focused Sponsor: Medical University of Warsaw Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time

Summary

This study sets up a registry to track children in Poland newly diagnosed with eosinophilic esophagitis (EoE), a condition where a type of white blood cell builds up in the esophagus and causes inflammation. Researchers will collect routine medical data—like symptoms, allergy history, lab results, and endoscopy findings—from about 250 children under 18. The goal is to describe the typical features of these patients and find where diagnosis and treatment can be improved.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
This registry could help doctors better understand how common eosinophilic esophagitis is in Polish children and identify ways to improve diagnosis and treatment for this condition.
What could go wrong
As an observational registry, it won't test any new treatment, and its findings may not apply to other countries or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

250 people

The number who actually took part.

Started

Jun 2024

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

ddd

Ages

Up to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age \< 18 years, * diagnosis of EZP based on medical history and histopathological examination of esophageal biopsies taken during gastroscopy (≥15 eosinophils/field of view in ≥1 biopsy), * consent of legal guardians and the child (in the case of patients ≥12 years of age) to participate in the study. Exclusion Criteria: * age \> 18 years, * inability of parents or guardians to give informed consent, * patients who did not consent to participate in the study (applies to patients \> 12 years of age), * congenital defects of the gastrointestinal tract, * status after surgery for gastrointestinal cancer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Eosinophilic disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

eosinophil disorder Eosinophilia eosinophilic esophagitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Eosinophilic disease Eosinophilic disorder Eosinophilic esophagitis (EOE) Gastroenterology Pediatric

Contacts and locations

Locations

  • Department of Paediatric Gastroenterology and Nutrition, Medical University of Warsaw

    Warsaw, 02-091, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.